Bilateral radiation recall pneumonitis during immunotherapy for an advanced renal cell carcinoma: A challenging case enhances the need for a multidisciplinary approach
The interplay between cancer cells and the immune system has offered a new field of research and multiple novel therapeutic opportunities. In particular, the interaction of programmed death 1 (PD-1) receptor expressed by immune cells and its ligand (PD-L1) expressed by cancer cells is a well-known mechanism of cancers' immune escape [1].
Source: European Journal of Cancer - Category: Cancer & Oncology Authors: Andrea De Giglio, Marta Scorsetti, Davide Franceschini, Francesco Massari, Andrea Ardizzoni Tags: Letter to the Editor Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Immunotherapy | Kidney Cancer | Renal Cell Carcinoma